Bain Capital Life Sciences Fund II, L.P.

10% owner at NewAmsterdam Pharma Co N.V. · on record since Dec 29, 2023
Director at Solid Biosciences Inc. · on record since Jan 12, 2024
10% owner at Xilio Therapeutics, Inc. · on record since Dec 10, 2021
10% owner at Solid Biosciences Inc. · on record since Dec 5, 2022

Insider trading activity of Bain Capital Life Sciences Fund II, L.P.

No transactions on record for Bain Capital Life Sciences Fund II, L.P..

Track record of Bain Capital Life Sciences Fund II, L.P.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Bain Capital Life Sciences Fund II, L.P.

Co-insiders of Bain Capital Life Sciences Fund II, L.P.

Bain Capital Life Sciences Investors II, LLCNewAmsterdam Pharma Co N.V. +2
Bain Capital Life Sciences Investors, LLCNewAmsterdam Pharma Co N.V. +2
BCIP Life Sciences Associates, LPNewAmsterdam Pharma Co N.V. +2
BCLS II Investco, LPNewAmsterdam Pharma Co N.V. +2
BCLS II Investo (GP), LLCNewAmsterdam Pharma Co N.V. +2
Adage Capital Management, L.P.Solid Biosciences Inc.
Alexandria Venture Investments, LLCXilio Therapeutics, Inc.
Amorrortu Pedro AlvaroSolid Biosciences Inc.
Arnold Matthew BennettSolid Biosciences Inc.
Atchinson RobertSolid Biosciences Inc.
Atlas Venture Associates Opportunity I, LLCXilio Therapeutics, Inc.
Atlas Venture Associates Opportunity I, L.P.Xilio Therapeutics, Inc.
Atlas Venture Associates XI, LLCXilio Therapeutics, Inc.
Atlas Venture Associates XI, L.P.Xilio Therapeutics, Inc.
Atlas Venture Fund XI, L.P.Xilio Therapeutics, Inc.
Atlas Venture Opportunity Fund I, L.P.Xilio Therapeutics, Inc.
Audet Juliette BerangereNewAmsterdam Pharma Co N.V.
Bain Capital Life Sciences Fund III, L.P.NewAmsterdam Pharma Co N.V.
Bain Capital Life Sciences III General Partner, LLCNewAmsterdam Pharma Co N.V.
Bain Capital Life Sciences Partners, LPSolid Biosciences Inc.
BAY CITY CAPITAL LLCXilio Therapeutics, Inc.
BCLS Fund III Investments GP, LLCNewAmsterdam Pharma Co N.V.
BCLS Fund III Investments, LPNewAmsterdam Pharma Co N.V.
BCLS II Equity Opportunities GP, LLCSolid Biosciences Inc.
BCLS II Equity Opportunities, LPSolid Biosciences Inc.
BCLS SB Investco, LPSolid Biosciences Inc.
Bello Akintunde OlatokumboXilio Therapeutics, Inc.
Blanchard Cheryl RXilio Therapeutics, Inc.
Bonstein SaraXilio Therapeutics, Inc.
Boxer Asset Management Inc.Solid Biosciences Inc.
Boxer Capital, LLCSolid Biosciences Inc.
Braslyn Ltd.Solid Biosciences Inc.
Brennan AoifeXilio Therapeutics, Inc.
Brennan Erin PowersSolid Biosciences Inc.
Brennan Kevin M.Xilio Therapeutics, Inc.
Brooks GabrielSolid Biosciences Inc.
Chudnovsky YekaterinaXilio Therapeutics, Inc.
CLACKSON TIMOTHY PXilio Therapeutics, Inc.
Clancy Paul JXilio Therapeutics, Inc.
Cumbo AlexanderSolid Biosciences Inc.
Curran Daniel J.Xilio Therapeutics, Inc.
Davidson Michael H.NewAmsterdam Pharma Co N.V.
DiPalma Stephen J.Solid Biosciences Inc.
Downing NicholasNewAmsterdam Pharma Co N.V.
EDELMAN JOSEPHSolid Biosciences Inc.
English Edward CXilio Therapeutics, Inc.
Estate of Ulrich RodeckXilio Therapeutics, Inc.
FIL LtdXilio Therapeutics, Inc.
FMR LLCXilio Therapeutics, Inc.
Forbion Capital Fund IV Cooperatief U.A.NewAmsterdam Pharma Co N.V.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →